Delivery of Prime Editors with a proprietary, universal liver-targeted LNP was well tolerated, with no safety concerns or detectable off-target edits observed across multiple preclinical studies On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback